Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Smart bomb for cancer therapy

15.09.2005


A new system for directing radiation to target cells has been developed in Melbourne, Australia. The new targeting system has the potential to specifically destroy cancer cells with minimal damage to healthy tissues.



Tom Karagiannis is a research officer from the Peter MacCallum Cancer Centre where the system was devised. Tom has been selected for Fresh Science, a national competition where early-career researchers present their work to the public for the first time.

One of the Fresh Scientists will win a trip to the UK courtesy of the British Council and present their work at the Royal Institution.


The new cancer targeting concept, for which an international patent is pending, uses a special class of radioactive atoms for which the radiation damage is confined to the molecules immediately adjacent to the radioactive atom.

The cell-killing effect is maximised by directing the radiation to the genetic material (DNA) of the target cell, with little effect on neighbouring cells.

“We expect that our targeting system will be particularly useful for small clusters of cancer cells, such as those that spread throughout the body when a cancer becomes more advanced,” says Dr Karagiannis.

Conventional cancer therapies such as surgery, radiotherapy and chemotherapy have resulted in a steady decline in cancer mortality rates over the years.

Only chemotherapy has the potential to be effective when the cancer has spread throughout the body, but often it is not effective.

Latest figures from the World Health Organization show that about 50 percent of cancer patients still die in developed countries and about 80 percent die in developing countries.

A unique feature of the cancer targeting system is the highly focussed damage caused by the radioactive isotopes used - most of the radiation damage is within a distance of only a few millionths of a millimetre. This means they can kill cancer cells without causing significant damage to normal cells.

The new technology combines knowledge from a wide range of scientific disciplines, including radiation biology, chemistry and immunology, Dr Karagiannis says.

The key ingredient is a complex composite drug, made by attaching the radioactive atom to a DNA-binding molecule, which in turn is linked to a cancer-targeting protein such as an antibody.

“Our radiolabelled DNA-binding drug alone provided a very efficient ‘molecular bomb’ for destroying cells,” says Dr Karagiannis. “But it could not discriminate between cancer cells and healthy cells.”

To make a ‘smarter’ drug, researchers took advantage of the fact that many cancer cells express high levels of certain proteins on their cell surface. Antibodies that bind specifically to these surface proteins were used as vehicles to target the lethal damage to cancer cells.

“Our strategy builds on the growing interest in antibodies as cancer therapeutics,” says Associate Professor Roger Martin, Tom’s supervisor who has been working on the project concept for the past three decades.

“There are a currently only a handful of such anticancer-antibodies that have been approved for therapy and many others that are in clinical trials.”

Proof-of-principle studies with the new targeting system have yielded very promising results with cell cultures, but a commercial partner is required for further development.

Niall Byrne | alfa
Further information:
http://www.scienceinpublic.com/sciencenow/2005/tomkaragiannis/tomkaragiannis.htm

More articles from Life Sciences:

nachricht The birth of a new protein
20.10.2017 | University of Arizona

nachricht Building New Moss Factories
20.10.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>